Pierre Azoulay

International Programs Professor of Management
Professor, Technological Innovation, Entrepreneurship, and Strategic Management


Pierre Azoulay

Pierre Azoulay is the International Programs Professor of Management at the MIT Sloan School of Management, and a Research Associate at the National Bureau of Economic Research.

His current research focuses on empirical studies of the supply of biomedical innovators, particularly at the interface of academia and the biopharmaceutical industry. He also is interested in the topic of academic entrepreneurship, having recently concluded a major study of the antecedents and consequences of academic patenting. In the past, he has investigated the impact of superstar researchers on the research productivity of their colleagues, and the outsourcing strategies of pharmaceutical firms, in particular the role played by contract research organizations in the clinical trials process.

At MIT Sloan, he teaches courses on competitive strategy and innovation strategy to the EMBA students and Sloan Fellows, as well as a PhD class on the economics of ideas, innovation, and entrepreneurship.

He holds a Diplôme d’Études Supérieures de Gestion from the Institut National des Télécommunications, an MA from Michigan State University, and a PhD in management from MIT.

Faculty Media

  • Why Restrictive Immigration May Be Bad for U.S. Entrepreneurship

    A new study shows that, relative to their population, immigrant-founded businesses create 42% more jobs in America than ones started by U.S.-born entrepreneurs.

  • MIT Economist’s Innovation Plan to Beat COVID-19

    MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.

  • Who Are the Most Successful Entrepreneurs? The Middle-Aged

    Sure, youth and innocence are great. But what if experience is even greater? We might get more innovation if we let the elders take the lead.

  • Small Research Teams ‘Disrupt’ Science More Radically Than Large Ones

    The application of a new citation metric prompts a reassessment of the relationship between the size of scientific teams and research impact, and calls into question the trend to emphasize ‘big...

  • Data Made to Matter Podcast: Big Payoffs from Public Science

    Prof. Pierre Azoulay on why many modern miracles of science wouldn't have been possible without NIH funding.

  • The Internet of “Stuff Your Mom Won’t Do for You Anymore”

    Platforms are what our friend Pierre Azoulay, an economist at MIT’s Sloan School of Management, calls “the internet of things your mom won’t do for you anymore.”

  • Ideas, Then Tech

    MIT Sloan's Pierre Azoulay takes a broad, conceptual view of how CUs need to embrace technology to drive innovation and market success.

  • Scientists Are Trying to Figure Out the Best Way to Spend Money on Science

    A provocative new study by two biologists appears at first glance to highlight a worrisome paradox: As the nation's investment in the science that underlies new therapies has increased over the...

  • Three Questions: Pierre Azoulay on the Value of Funding the NIH

    New study shows publicly funded research spurs private drug development.

  • How the 'Matthew Effect' Helps Some Scientific Papers Gain Popularity

    A new study co-authored by an MIT economist reports that high-status authorship increases how frequently papers are cited in the life sciences but finds some subtle twists in how this happens. "We...


Contact Information

Phone: (617) 258-9766
Fax: (617) 253-2660
Email: pazoulay@mit.edu
Website: http://pazoulay.scripts.mit.edu/
Support Staff
Name: Natalia Kalas
Phone: (617) 253-6621

Teaches In

Developing and Managing a Successful Technology Strategy Feb 4-12, 2021 | May 20-21, 2021 | Jul 7-8, 2021

Platform Strategy: Building and Thriving in a Vibrant Ecosystem Jan 14-15, 2021 | Mar 25-26, 2021 | May 24-25, 2021

Faculty Insights

Pierre Azoulay on Platform Strategy: Building and Thriving in a Vibrant Ecosystem.

Data Made to Matter Podcast: Big Payoffs from Public Science

Prof. Pierre Azoulay on why many modern miracles of science wouldn't have been possible without NIH funding.